title: From bench to bedside: use of human adipose-derived stem cells.
abstract: Since the discovery of adipose-derived stem cells (ASC) in human adipose tissue nearly 15 years ago, significant advances have been made in progressing this promising cell therapy tool from the laboratory bench to bedside usage. Standardization of nomenclature around the different cell types used is finally being adopted, which facilitates comparison of results between research groups. In vitro studies have assessed the ability of ASC to undergo mesenchymal differentiation as well as differentiation along alternate lineages (transdifferentiation). Recently, focus has shifted to the immune modulatory and paracrine effects of transplanted ASC, with growing interest in the ASC secretome as a source of clinical effect. Bedside use of ASC is advancing alongside basic research. An increasing number of safety-focused Phase I and Phase IIb trials have been published without identifying any significant risks or adverse events in the short term. Phase III trials to assess efficacy are currently underway. In many countries, regulatory frameworks are being developed to monitor their use and assure their safety. As many trials rely on ASC injected at a distant site from the area of clinical need, strategies to improve the homing and efficacy of transplanted cells are also being explored. This review highlights each of these aspects of the bench-to-bedside use of ASC and summarizes their clinical utility across a variety of medical specialties.
authors.affiliation: Dunbar Laboratory, School of Biological Sciences, The University of Auckland, Auckland, New Zealand.
authors.forename: Vaughan
authors.initials: V
authors.lastname: Feisst
authors.affiliation: Dunbar Laboratory, School of Biological Sciences, The University of Auckland, Auckland, New Zealand.
authors.forename: Sarah
authors.initials: S
authors.lastname: Meidinger
authors.affiliation: Department of Surgery, Faculty of Medicine and Health Sciences, The University of Auckland, Auckland, New Zealand.
authors.forename: Michelle B
authors.initials: MB
authors.lastname: Locke
keywords: bystander effect; mesenchymal stem cells; standardization; stromal cells; stromal vascular fraction